Sortis Pharma

Executive Summary

Sortis Pharma is a private Indian contract development and manufacturing organization (CDMO) founded in 2020 and headquartered in Hyderabad. The company provides end-to-end R&D services including pre-formulation, formulation development, analytical testing, stability studies, and technology transfer for oral, injectable, and topical dosage forms. With a workforce of 50-200 employees, Sortis Pharma caters to the growing global demand for cost-effective pharmaceutical outsourcing, leveraging India's established manufacturing ecosystem. Although the company operates in a competitive landscape with many CDMOs, its focus on comprehensive services and recent entry positions it for potential growth as it builds a client base and reputation. Due to limited public financial and pipeline details, the company's near-term prospects are moderately attractive but carry execution risk.

Upcoming Catalysts (preview)

• 2027Facility expansion or new capacity addition65% success
• TBDStrategic partnership with a major pharmaceutical company60% success
• TBDUS FDA approval of manufacturing facility60% success